Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | SGR-1505 |
| Synonyms | |
| Therapy Description |
SGR-1505 inhibits MALT1, leading to decreased Malt1 signaling and potentially resulting in reduced T-regulatory cell-mediated immunosuppression and decreased tumor cell growth (NCI Thesaurus). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| SGR-1505 | SGR 1505|SGR1505 | MALT1 Inhibitor 6 | SGR-1505 inhibits MALT1, leading to decreased Malt1 signaling and potentially resulting in reduced T-regulatory cell-mediated immunosuppression and decreased tumor cell growth (NCI Thesaurus). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT05544019 | Phase I | SGR-1505 | Study of SGR-1505 in Mature B-Cell Neoplasms | Recruiting | USA | ROU | POL | ITA | FRA | ESP | 2 |